Microcap Potential Homeruns--Credible, and Reporting Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Microcap Potential Homeruns--Credible, and Reporting

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: thomas a. burke who wrote (709)	1/24/2011 8:26:42 PM
From: NAG1	Read Replies (1) of 1056

Thomas, Here is a link to the PDF of the updated guidance. instacare.net The highlight is the 65 million estimate for pharma tech with an operating profit of 14.9 million for the upcoming year. With 100 million shares outstanding, that would be a profit of 15 cents per share. With a PE of 30, that would put the share price around 4-5 dollars a share. It would be nice if the analysis would be put out in a press release for a wider audience. Hopefully the report is accurate and not something that is put out by some boilerplate type of company. This is what I was able to come up with quickly. investing.businessweek.com. Any opinions on this is greatly appreciated. Neal

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next